Each DR [Delayed Release] Vegetable Capsule contains Probiotics : Not Less than 15 Billion CFU (Streptococcus thermophilus ,Lactobacillus acidophilus,Bifidobacterium longum and Lactitol Monohydrate-100mg
RENOTOXE an oral synbiotic therapy of selected microbial strains helps in reno-protection via intra -intestinal degradation of toxic wastes solutes in patients with chronic kidney diseases. Supports bloodstream concentrations of nitrogenous waste metabolites in the bowel and also stabilizes healthy gut flora.
RENOTOXE targets metabolized nitrogenous wastes that diffuse from the bloodstream into the bowel. These naturally occurring eneteric microbes have the ability to metabolize and thus consume the nitrogenous waste products.Streptococcus thermophilus is a high urease or urease utilizing microbe Lactic acid bacillus in RENOTOXE is non pathogenic live spore which can germinate in intestine, survive in gastric acidity and proliferates with inherent potentiality. Exhibits adhesion capacity on par with resident flora. Exhibits a symbiotic relationship with the host and promotes metabolic activities. L.acidophillus primarily found in small intestine helps in control of intestinal infections. Bifidobacterium longum helps in replacement of puterefective bacteria in the intestine and reduce the toxic substances in the gut.
Azotemia / Uremia
Reduction of Nephrotoxicity To delay the need of dialysis in CKD patients /HD Patients
Control complications of CKD
Dosage & Duration:
One Vegeterian Capsule T.I.D or as Directed by the Physician
Adverse Effects :
As Probiotic bacteria of natural origin, there are no known adverse effects recorded as these agents have been classified as GRAS [Generally Recommended as Safe] by FDA
5 x 10 Capsules per Box